Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hevener, A. L.
Right arrow Articles by Olefsky, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hevener, A. L.
Right arrow Articles by Olefsky, J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 49, Issue 12 2154-2159, Copyright © 2000 by American Diabetes Association


ARTICLES

Exercise and thiazolidinedione therapy normalize insulin action in the obese Zucker fatty rat

AL Hevener, D Reichart and J Olefsky
Department of Medicine, University of California, San Diego 92093-0673, USA.

Thiazolidinediones and exercise are both known to improve insulin action independently. Therefore, we determined whether combined therapy could normalize insulin action in the Zucker fatty (ZF) rat. Rats were fed troglitazone as a 0.2% food admixture over a 3-week exercise training period (treadmill running 5 days/week, 20 m/min, 0% grade, 60 min/day). Subsequent to drug and/or exercise therapy, animals were chronically cannulated in the carotid artery (sampling) and jugular vein (infusion). After a 4-day recovery from surgery, animals were exposed to a hyperinsulinemic (40 mU x kg(-1) x min(-1)) euglycemic clamp (8.5 +/- 0.12 mmol/l; P = 0.45 between groups). Independently, exercise (n = 7) and troglitazone (n = 7) improved the glucose disposal rate 20% (P = 0.04) and 76% (P = 0.001), respectively, when compared with untreated ZF controls (n = 11). In combination, exercise and troglitazone therapy (n = 6) produced significant increments in the following: tracer-determined glucose disposal rate (combined therapy, 52.4 +/- 2.9 mg x kg(-1) x min(-1), vs. untreated ZF, 25.8 +/- 0.8 mg x kg(-1) x min(-1); P = 0.0001), total GLUT4 protein (twofold increase; P = 0.001), insulin receptor substrate (IRS)-1 protein (fourfold increase; P = 0.0001), and Akt phosphorylation (2.9-fold increase; P = 0.002). In conclusion, 1) exercise and troglitazone therapy each improved insulin action in the ZF rat, whereas the combination of the two led to complete normalization of insulin sensitivity, and 2) combination treatment also resulted in normalization of GLUT4 total protein, IRS-1 protein, and Akt phosphorylation compared with lean littermates.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. B. Yaspelkis III, S. J. Lessard, D. W. Reeder, J. J. Limon, M. Saito, D. A. Rivas, I. Kvasha, and J. A. Hawley
Exercise reverses high-fat diet-induced impairments on compartmentalization and activation of components of the insulin-signaling cascade in skeletal muscle
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E941 - E949.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. J. Lessard, D. A. Rivas, Z.-P. Chen, A. Bonen, M. A. Febbraio, D. W. Reeder, B. E. Kemp, B. B. Yaspelkis III, and J. A. Hawley
Tissue-Specific Effects of Rosiglitazone and Exercise in the Treatment of Lipid-Induced Insulin Resistance
Diabetes, July 1, 2007; 56(7): 1856 - 1864.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. B. Dokken and E. J. Henriksen
Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats
Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E207 - E213.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Lopez-Soriano, C. Chiellini, M. Maffei, P. A. Grimaldi, and J. M. Argiles
Roles of Skeletal Muscle and Peroxisome Proliferator-Activated Receptors in the Development and Treatment of Obesity
Endocr. Rev., May 1, 2006; 27(3): 318 - 329.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. D'Angelo, A. A. Elmarakby, D. M. Pollock, and D. W. Stepp
Fructose Feeding Increases Insulin Resistance but Not Blood Pressure in Sprague-Dawley Rats
Hypertension, October 1, 2005; 46(4): 806 - 811.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. M. Lemieux, C. J. Diehl, J. A. Sloniger, and E. J. Henriksen
Voluntary exercise training enhances glucose transport but not insulin signaling capacity in muscle of hypertensive TG(mREN2)27 rats
J Appl Physiol, July 1, 2005; 99(1): 357 - 362.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. Saengsirisuwan, F. R. Perez, J. A. Sloniger, T. Maier, and E. J. Henriksen
Interactions of exercise training and {alpha}-lipoic acid on insulin signaling in skeletal muscle of obese Zucker rats
Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E529 - E536.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. Lajoie, A. Calderone, F. Trudeau, N. Lavoie, G. Massicotte, S. Gagnon, and L. Beliveau
Exercise training attenuated the PKB and GSK-3 dephosphorylation in the myocardium of ZDF rats
J Appl Physiol, May 1, 2004; 96(5): 1606 - 1612.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. D. Krisan, D. E. Collins, A. M. Crain, C. C. Kwong, M. K. Singh, J. R. Bernard, and B. B. Yaspelkis III
Resistance training enhances components of the insulin signaling cascade in normal and high-fat-fed rodent skeletal muscle
J Appl Physiol, May 1, 2004; 96(5): 1691 - 1700.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. J. Wilkes, A. Hevener, and J. Olefsky
Chronic Endothelin-1 Treatment Leads to Insulin Resistance In Vivo
Diabetes, August 1, 2003; 52(8): 1904 - 1909.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
W. J. Banz, M. A. Maher, W. G. Thompson, D. R. Bassett, W. Moore, M. Ashraf, D. J. Keefer, and M. B. Zemel
Effects of Resistance versus Aerobic Training on Coronary Artery Disease Risk Factors
Experimental Biology and Medicine, April 1, 2003; 228(4): 434 - 440.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Hallsten, K. A. Virtanen, F. Lonnqvist, H. Sipila, A. Oksanen, T. Viljanen, T. Ronnemaa, J. Viikari, J. Knuuti, and P. Nuutila
Rosiglitazone but Not Metformin Enhances Insulin- and Exercise-Stimulated Skeletal Muscle Glucose Uptake in Patients With Newly Diagnosed Type 2 Diabetes
Diabetes, December 1, 2002; 51(12): 3479 - 3485.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. A. Pospisilik, S. G. Stafford, H.-U. Demuth, C. H.S. McIntosh, and R. A. Pederson
Long-Term Treatment With Dipeptidyl Peptidase IV Inhibitor Improves Hepatic and Peripheral Insulin Sensitivity in the VDF Zucker Rat: A Euglycemic-Hyperinsulinemic Clamp Study
Diabetes, September 1, 2002; 51(9): 2677 - 2683.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. M. Meyer, K. Levin, T. Grimmsmann, N. Perwitz, A. Eirich, H. Beck-Nielsen, and H. H. Klein
Troglitazone Treatment Increases Protein Kinase B Phosphorylation in Skeletal Muscle of Normoglycemic Subjects at Risk for the Development of Type 2 Diabetes
Diabetes, September 1, 2002; 51(9): 2691 - 2697.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E. J. Henriksen
Exercise Effects of Muscle Insulin Signaling and Action: Invited Review: Effects of acute exercise and exercise training on insulin resistance
J Appl Physiol, August 1, 2002; 93(2): 788 - 796.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Jiang, Q. Dallas-Yang, Z. Li, D. Szalkowski, F. Liu, X. Shen, M. Wu, G. Zhou, T. Doebber, J. Berger, et al.
Potentiation of Insulin Signaling in Tissues of Zucker Obese Rats After Acute and Long-Term Treatment With PPAR{gamma} Agonists
Diabetes, August 1, 2002; 51(8): 2412 - 2419.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. M. Jucker, T. R. Schaeffer, R. E. Haimbach, T. S. McIntosh, D. Chun, M. Mayer, D. H. Ohlstein, H. M. Davis, S. A. Smith, A. R. Cobitz, et al.
Normalization of Skeletal Muscle Glycogen Synthesis and Glycolysis in Rosiglitazone-Treated Zucker Fatty Rats: An In Vivo Nuclear Magnetic Resonance Study
Diabetes, July 1, 2002; 51(7): 2066 - 2073.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y.-B. Kim, T. P. Ciaraldi, A. Kong, D. Kim, N. Chu, P. Mohideen, S. Mudaliar, R. R. Henry, and B. B. Kahn
Troglitazone but not Metformin Restores Insulin-Stimulated Phosphoinositide 3-Kinase Activity and Increases p110{beta} Protein Levels in Skeletal Muscle of Type 2 Diabetic Subjects
Diabetes, February 1, 2002; 51(2): 443 - 448.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2000 by the American Diabetes Association.